Andreas Norlin

Hoofd Techniek/Wetenschap/O&O bij ASCELIA PHARMA AB

Vermogen: 12 367 $ op 31-05-2024

54 jaar

Health Technology

Consumer Services

Technology Services

Actieve functies van Andreas Norlin

Bedrijven	Functie	Begin	Einde
ASCELIA PHARMA AB	Hoofd Techniek/Wetenschap/O&O	01-01-2020	-
ApoGlyx AB ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden.	Directeur/Bestuurslid	-	-
Desupervised ApS Desupervised ApS Information Technology ServicesTechnology Services Part of Hamiltonian Holding ApS, Desupervised ApS is a Danish company that provides artificial intelligence software services. The company is based in Copenhagen, Denmark.	Directeur/Bestuurslid	-	-

Bedrijven	Functie	Begin	Einde
Xkout Bioscience AB	Oprichter	-	-

University of Lund

Doctorate Degree

Internationaal

Zweden	5
Denemarken	2

Operationeel

Sectoraal

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Beursgenoteerde bedrijven	1
ASCELIA PHARMA AB	Health Technology

Bedrijven in privébezit	3
ApoGlyx AB ApoGlyx AB BiotechnologyHealth Technology ApoGlyx AB engages in research and development of aquaporin inhibitors. It conducts sales of know-how, licenses, and chemical substance in biochemistry. The company was founded by Per Ola Kjellbom on April 22, 2008 and is headquartered in Lund, Sweden.	Health Technology
Xkout Bioscience AB
Desupervised ApS Desupervised ApS Information Technology ServicesTechnology Services Part of Hamiltonian Holding ApS, Desupervised ApS is a Danish company that provides artificial intelligence software services. The company is based in Copenhagen, Denmark.	Technology Services